摘要:
Disclosed are apparatuses for detecting glucose levels in a subject. The apparatuses include a glucose sensor coupled with an anti-inflammatory module. The apparatus is configured to monitor blood glucose by detecting the fluorescence generated by the sensor and simultaneously reduce the tissue inflammation reaction. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems.
摘要:
The subject invention provides nanoparticle drug delivery systems and methods of making and using the same. In one aspect, the present invention provides a nanoparticle drug delivery system comprising a magnetic nanoparticle (MNP) encapsulated by at least one bilayer coating comprising a layer of drug molecules and a layer of polymer. In another aspect, a method of using the nanoparticle drug delivery system can include: administering the nanoparticle drug delivery system systemically and localizing the nanoparticles to the target treatment area. In embodiments the nanoparticle drug delivery system is used to treat HIV-AIDS.
摘要:
Disclosed are apparatuses for detecting glucose levels in a subject. The apparatuses include a glucose sensor coupled with an anti-inflammatory module. The apparatus is configured to monitor blood glucose by detecting the fluorescence generated by the sensor and simultaneously reduce the tissue inflammation reaction. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems.